GFactory Competitors

Ascensia Diabetes Care is a global company dedicated to improving the lives of people with diabetes and helping empower them to take charge of their health and happiness. Our goal is to provide products and solutions that make a positive, daily difference for people with diabetes. We want to help make sure diabetes doesn’t get in the way of people’s future, enabling them to live richer lives. At Ascensia Diabetes Care we want to serve the needs of patients through our innovation and specialized expertise in diabetes. We create high quality solutions and precision tools that help patients manage their condition and take charge of their lives. Innovation is in our DNA and we are agile, entrepreneurial and dynamic in the way we operate. Ascensia Diabetes Care was established in 2016 through the acquisition of Bayer Diabetes Care by Panasonic Healthcare Holdings. We have been serving people with diabetes for over 80 years and our portfolio includes the world-renowned CONTOUR range of blood glucose monitoring systems. We are proud of our heritage as a leading provider of solutions for diabetes care. We are excited by what the future holds and will continue to build on the legacy of our longstanding commitment to diabetes.

Empowering People to Take Control of Health Dexcom Corporation (NASDAQ DXCM) has been a pioneer in glucose sensing for more than 25 years. Since 1999, we have developed innovative technologies that transformed how people manage diabetes. Our products are part of people’s daily lives, empowering them to live confidently and feel more in control, free to pursue their dreams. Headquartered in San Diego, California, with operations around the world, Dexcom leads by listening to the needs of users, caregivers, and providers, to simplify and improve glucose management.

For 15 years, Omada Health has been in the corner of millions of Americans managing chronic conditions. We help our members between doctor visits, providing virtual care that adapts to real life. We partner with employers, health plans, pharmacy benefit managers, and government agencies to support their populations across common chronic conditions — from prediabetes, diabetes, and hypertension to muscle and joint pain— all through the convenience of an app. Our programs also adapt to provide specialized care for GLP-1 journeys. At Omada, care isn’t built for perfection. It’s built for real people. Our clinically-validated programs combine human connection with modern technology, pairing members with real coaches and care teams. Omada’s impact is proven: our outcomes are published in 30 peer-reviewed studies, showing lasting behavior change, reduced healthcare costs, and ROI for our partners. Our success starts with our people. Omada’s strong, inclusive culture has earned us the Great Place to Work certification, and in 2025 we became a Nasdaq-listed company — a milestone on our mission to bend the curve of chronic disease.